Viewing Study NCT06764160


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-02-22 @ 4:14 AM
Study NCT ID: NCT06764160
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-28
First Post: 2024-12-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module